Eric R. Siegel

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu

Amanda N. Fader, Dana M. Roque, Eric R. Siegel et al. · Journal of Clinical Oncology · 2018 · 509 citations · Full text

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy

Maurizio Zangari, Elias Anaissie, Bart Barlogie et al. · Blood · 2001 · 496 citations · Full text

Thiazolidinediones and the Risk of Lung, Prostate, and Colon Cancer in Patients With Diabetes

Rangaswamy Govindarajan, Luke D. Ratnasinghe, Debra L. Simmons et al. · Journal of Clinical Oncology · 2007 · 328 citations · Full text

Results of autologous stem cell transplant in multiple myeloma patients with renal failure

Ashraf Badros, Bart Barlogie, Eric R. Siegel et al. · British Journal of Haematology · 2001 · 306 citations · Full text

Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis

Amanda N. Fader, Dana M. Roque, Eric R. Siegel et al. · Clinical Cancer Research · 2020 · 292 citations · Full text